Glioblastoma: Molecular Pathways, Stem Cells and Therapeutic Targets
Author:
Publisher
MDPI AG
Subject
Cancer Research,Oncology
Link
http://www.mdpi.com/2072-6694/7/2/538/pdf
Reference87 articles.
1. Improving prognosis of glioblastoma in the 21st century: Who has benefited most?
2. Malignant Gliomas in Adults
3. CBTRUS statistical report: primary brain and central nervous system tumors diagnosed in the United States in 2007–2011;Ostrom;NeuroOncology,2014
4. Malignant astrocytic glioma: genetics, biology, and paths to treatment
5. Overexpression of the EGF Receptor and p53 Mutations are Mutually Exclusive in the Evolution of Primary and Secondary Glioblastomas
Cited by 103 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. An altered metabolic landscape drives quiescence to the reawakening of cancer stem cells;Cancer Stem Cells and Signaling Pathways;2024
2. Identification of DNA Damage Repair Gene Signature as a Novel Prognostic Marker in Glioblastoma Multiforme;World Neurosurgery;2023-08
3. L1CAM deployed perivascular tumor niche promotes vessel wall invasion of tumor thrombus and metastasis of renal cell carcinoma;Cell Death Discovery;2023-04-04
4. TLR9 and Glioma: Friends or Foes?;Cells;2022-12-30
5. MiR-33a targets FOSL1 and EN2 as a clinical prognostic marker for sarcopenia by glioma;Frontiers in Genetics;2022-08-17
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3